Healthcare Unusual Volume: Sagent Pharmaceuticals (NASDAQ:SGNT), Ambit Biosciences Corp (NASDAQ:AMBI), Accelerate Diagnostics (NASDAQ:AXDX), DURECT Corporation (NASDAQ:DRRX), EDAP TMS S.A. (ADR) (NASDAQ:EDAP)

Sagent Pharmaceuticals Inc. (NASDAQ:SGNT) will replace LaSalle Hotel Properties in the S&P SmallCap 600. Sagent Pharmaceuticals Inc. (NASDAQ:SGNT) net profit margin is 9.70% and weekly performance is 4.70%. On last trading day company shares ended up $25.86. Analysts mean target price for the company is $23.71. Sagent Pharmaceuticals Inc. (NASDAQ:SGNT) distance from 50-day simple moving average (SMA50) is 16.61%.

Equities researchers at TheStreet initiated coverage on shares of Ambit Biosciences Corp (NASDAQ:AMBI) in a research report issued on Wednesday. The firm set a “sell” rating on the stock. Ambit Biosciences Corp (NASDAQ:AMBI) shares advanced 0.14% in last trading session and ended the day on $6.91. AMBI return on assets is -17.50%.Ambit Biosciences Corp (NASDAQ:AMBI) quarterly performance is -23.98%.

The 2014 Annual Meeting of Stockholders of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) was held on May 29, 2014. At the meeting, Lawrence Mehren, Mark C. Miller, John Patience, Jack Schuler, Matthew W. Strobeck, Ph.D. and Frank J.M. ten Brink were elected as directors, each to hold office until the Company’s next Annual Meeting of Stockholders or until his successor is elected and qualified. A proposed amendment to the Company’s 2012 Omnibus Equity Incentive Plan increasing the number of shares of the Company’s common stock reserved and available for grant thereunder by 4,000,000 shares and the Audit Committee’s appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2014 were also approved and ratified, respectively, at the meeting. Accelerate Diagnostics Inc. (NASDAQ:AXDX) shares moved down -13.56% in last trading session and was closed at $26.00, while trading in range of $25.00 – $30.24. Accelerate Diagnostics Inc. (NASDAQ:AXDX) year to date (YTD) performance is 113.11%.

DURECT Corporation (NASDAQ:DRRX) on 27 June announced that it had entered into a Loan and Security Agreement (the “Loan Agreement”) with Oxford Finance LLC, pursuant to which Oxford agreed to make a term loan to the company in the principal amount of $20 million. DURECT Corporation (NASDAQ:DRRX) ended the last trading day at $1.82. Company weekly volatility is calculated as 6.21% and price to cash ratio as 11.30.DURECT Corporation (NASDAQ:DRRX) showed a positive weekly performance of 14.47%.

HC Wainwright started coverage on shares of Edap – Tms SA (NASDAQ:EDAP) in a research report sent to investors on Monday morning, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $6.00 price target on the stock. EDAP TMS S.A. (ADR) (NASDAQ:EDAP) net profit margin is -1.40% and weekly performance is 12.67%. On last trading day company shares ended up $4.98. Analysts mean target price for the company is $6.00. EDAP TMS S.A. (ADR) (NASDAQ:EDAP) distance from 50-day simple moving average (SMA50) is 42.04%.